Physicians' Academy for Cardiovascular Education

New ACC/AHA hypertension guidelines empasize risk assessment

Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Prof. Clyde Yancy - Chicago, IL, USA

Good BP measurement depends more on appropriate technique than on absence of staff

Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Karen Johnson - Memphis, TN, USA

Target for BP lowering differs between Europe and USA

Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Prof. Clyde Yancy - Chicago, IL, USA

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

New ACC/AHA Hypertension Guidelines: stress on accuracy BP measurement method and lifestyle changes ánd a new target

Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Paul Whelton, MD (Tulane University, New Orleans, LA, USA

BP lowering with endovascular baroreflex amplification in resistant hypertension: the CALM-FIM study

Aug. 29, 2017 - Dr. Wilko Spiering - UMCU

Take home messages of the ESC congress for better hypertension treatment

Aug. 29, 2017 - Dr. Clyde Jancy - Northwestern University, Feinberg University, Chicago, IL, VS

Well-conducted trial confirms principle that renal denervation can lower blood pressure

Aug. 29, 2017

NSAID ibuprofen increases blood pressure significantly more than other selective COX2 inhibitors

Aug. 28, 2017

E-counselling improves adherence in hypertensives

Mar. 21, 2017 - Dr. Rob Nolan, Toronto, ONT, Canada

Get involved in May Measurement Month!

Jan. 22, 2017 - London, United Kingdom - Prof. Neil R Poulter, MD (London, UK) - ISH President

How low to go with blood pressure: J-curve or not?

Nov. 12, 2016 - New Orleans, LA, USA - Deepak L.Bhatt, MD, MPH (Boston, MA, USA)

To SPRINT or not to SPRINT to a lower blood pressure target?

Aug. 29, 2016 - ESC Rome, Italy - William C Cushman (Memphis, TN, USA) and Sverre E Kjeldsen (Oslo, Norway)
##SCROLLER_ITEMS_FULL_TITLE##

BP-lowering medication should not be used in normotensive primary prevention population at intermediate CV risk

May 10, 2016 - ACC 2016, Chicago, IL, USA - Eva Lonn (Hamilton, ONT, Canada)
##SCROLLER_ITEMS_FULL_TITLE##

HOPE-3: Statin therapy works in everybody with intermediate-risk

Apr. 8, 2016 - Salim Yusuf MD, McMaster University, Hamilton, Ontario
##SCROLLER_ITEMS_FULL_TITLE##

PARAMETER: heart failure agent to treat hypertension

Aug. 31, 2015 - ESC - Londen 2015 - Bryan Williams
##SCROLLER_ITEMS_FULL_TITLE##

PARAMETER: heart failure agent to treat hypertension

Sep. 1, 2015 - ESC - Londen 2015 - Bryan Williams
##SCROLLER_ITEMS_FULL_TITLE##

PATHWAY-2: which agent can best treat therapy resistant hypertension?

Aug. 31, 2015 - ESC - Londen 2015 - Bryan Williams
##SCROLLER_ITEMS_FULL_TITLE##

PARADIGM-HF: Rationale, results & implications

Dec. 11, 2014 - Chicago, Il, USA VBWG - John J McMurray
##SCROLLER_ITEMS_FULL_TITLE##

CV Risk management in Russia

Dec. 3, 2014 - Moscow - Prof Andrey Susekov
##SCROLLER_ITEMS_FULL_TITLE##

Innovating hypertension: targeting the underlying disease process

Sep. 8, 2014 - Barcelona - Prof Bryan Williams
##SCROLLER_ITEMS_FULL_TITLE##

Innovating hypertension management beyond current therapies: What are the opportunities?

Sep. 6, 2014 - Snapshot 2014 - Prof. Bryan Williams, UCL, London, United Kingdom
##SCROLLER_ITEMS_FULL_TITLE##

Are new hypertension guidelines helpful for patients at high risk?

May 23, 2014 - CDMC Almaty - Dr Peter Meredith, Glasgow
##SCROLLER_ITEMS_FULL_TITLE##

Improving BP measurement for better hypertension management

Apr. 25, 2014 - CDMC Almaty - Prof Luis Ruilope, Madrid, Spain
##SCROLLER_ITEMS_FULL_TITLE##

New British guidelines and risk calculator on CV Risk (JBS3)

Apr. 7, 2014 - ACC 2014 - Prof John E Deanfield
##SCROLLER_ITEMS_FULL_TITLE##

Update on therapy-resistant hypertension: Novel pharmacotherapy or renal denervation?

Sep. 14, 2013
##SCROLLER_ITEMS_FULL_TITLE##

Therapy resistant hypertension: novel pharmacotherapy or renal denervation?

Sep. 10, 2013 - Amsterdam, August 31, 2013 - Luis Ruilope
##SCROLLER_ITEMS_FULL_TITLE##

Blood Pressure: Does it matter how to lower it?

June 20, 2013 - CVRMC Kuala Lumpur - Prof. Peter Sever
##SCROLLER_ITEMS_FULL_TITLE##

The unmet need for controlling hypertension

June 17, 2013 - VBWG San Francisco - Dr. Domenic Sica
##SCROLLER_ITEMS_FULL_TITLE##

Preview on new hypertension guidelines

May 8, 2013 - CDMC Hanoi - Prof Michael A Weber

BP before start therapy affects the relative benefit of BP-lowering therapy

Jan. 10, 2018 - Brunström M and Carlberg B. - JAMA Intern Med. 2018

A meta-analysis shows that the relative benefit of BP-lowering is evident when baseline SBP is ≥140mmHg, but not if it is <140 mmHg, particularly in primary prevention.

New ACC/AHA hypertension guidelines empasize risk assessment

AHA 2017 - Anaheim, CA, VS

Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Prof. Clyde Yancy - Chicago, IL, USA
Prof. Clyde Yancy summarizes the most important new recommendations, starting with a new definition of hypertension, the need for a risk conversation and implications for therapy.

AHA 2017 Prof. Clyde Yancy summarizes the most important new recommendations, starting with a new definition of hypertension, the need for a risk conversation and implications for therapy.

Good BP measurement depends more on appropriate technique than on absence of staff

AHA 2017 - Anaheim, CA, USA

Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Karen Johnson - Memphis, TN, USA
in the SPRINT study, BP was not always measured in absence of a physician or nurse. A posthoc survey investigated whether this affected the findings of the study.

AHA 2017 In the SPRINT study, BP was not always measured in absence of a physician or nurse. A posthoc survey investigated whether this affected the findings of the study.

Target for BP lowering differs between Europe and USA

AHA 2017 - Anaheim, CA, USA

Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Prof. Clyde Yancy - Chicago, IL, USA
Although the broad statements remain intact, the target for BP lowering differs between Europe and USA. Prof Yancy explains the reasons for the differences in target of BP lowering between the 2 continents.

AHA 2017Although the broad statements remain intact, the target in BP lowering differs between Europe and USA; prof Yancy explains why.

New ACC/AHA Hypertension Practice Guidelines stress lifestyle improvement and lower SBP target

Nov. 14, 2017 - news
The new guidelines now define hypertension as >130/80 mmHg, emphasize the need for lifestyle changes and specify details of accurate BP measurement methods.

AHA 2017 The new guidelines now define hypertension as >130/80 mmHg, emphasize the need for lifestyle changes and specify details of accurate BP measurement methods.

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

AHA 2017 - Anaheim, CA, USA

Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.
A lot of variation in BP measurement methods was seen in SPRINT, despite the protocol, but in 3/4 of sites patients were alone at least at some point during the BP reading.

AHA 2017 A lot of variation in BP measurement methods was seen in SPRINT, despite the protocol, but in 3/4 of sites patients were alone at least at some point during the BP reading.

New ACC/AHA Hypertension Guidelines: stress on accuracy BP measurement method and lifestyle changes ánd a new target

AHA 2017 - Anaheim, CA, USA

Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Paul Whelton, MD (Tulane University, New Orleans, LA, USA
Paul Whelton, chair of the 2017 Hypertension Practice Guidelines, summarises the major changes as compared with the previous guideline.

AHA 2017 Paul Whelton, chair of the 2017 Hypertension Practice Guidelines, summarises the major changes as compared with the previous guideline.

Bariatric surgery induced remission of hypertension in obese patients and diminishes medication

Presented at AHA 2017 Scientific Sessions in Anaheim, CA, USA by Carlos Schiavon (Heart Hospital, Sao Paulo, Brazil

Nov. 14, 2017 - news

AHA 2017 Gastric bypass in obese hypertensives (BMI 30-39.9) led to stable BP and reduction of medication need in the majority of patients, and about half showed remission after 1 year.

Midlife hypertension is associated with an increased risk of dementia in women

Oct. 19, 2017 - Gilsanz P, et al. - Neurology 2017

Although midlife hypertension is more common in men, it was only associated with the risk of dementia in women, suggesting that hypertension is a modifiable risk factor for dementia in women.

Greater reduction of LV mass index with ARNI than with ARB in hypertensive patients

Oct. 10, 2017 - Schmieder RE et al. - Eur Heart J 2017

In a double-blind, randomized study, treatment with sacubitril/valsartan in hypertensive patients reduced the LV mass index to a greater extent than olmesartan.

BP lowering with endovascular baroreflex amplification in resistant hypertension: the CALM-FIM study

Aug. 29, 2017 - Dr. Wilko Spiering - UMCU
Dr. Wilko Spiering summarises the results of the CALM-FIM study, showing that endovascular baroreflex amplification with MobiusHD device lowers BP in resistant hypertension.

ESC 2017 Dr. Wilko Spiering summarises the results of the CALM-FIM study, showing that endovascular baroreflex amplification with MobiusHD device lowers BP in resistant hypertension.

Intensive BP control benefits diabetic patients at high CV risk

Oct. 5, 2017 - Buckley LF et al. - Diabetes Care 2017;

In a SPRINT-eligible ACCORD-BP population, a high-risk cohort of diabetic patients, intensive BP control at a goal of <120 mmHg, reduced CVD outcomes.